SYNAGEVA BIOPHARMA CORP. — Form D
SYNAGEVA BIOPHARMA CORP. of LEXINGTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2009-04-16. The offering totals $45.0M, of which $30.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2009-04-16
- Form: D
- Accession: 0001017163-09-000004
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $45.0M
- Amount sold: $30.2M
- Remaining: $14.8M
- Investors: 18
- Date of first sale: 2009-04-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-66553
Issuer
- Name: SYNAGEVA BIOPHARMA CORP.
- CIK: 0001017163
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 128 SPRING STREET, SUITE 520, LEXINGTON, MA, 02421
- Phone: 781-357-9900
Officers, directors & promoters (22)
| Name | Role | Location |
|---|
| Felix Baker | Director | New York, NY |
| Mark J Goldberg | Director | Dallas, TX |
| THOMAS MALLEY | Director | SAN DIEGO, CA |
| Mark Goldberg | Director | San Francisco, CA |
| JAMES LL TULLIS | Director | PALM BEACH GARDENS, FL |
| STEPHEN R BIGGAR | Director | HAMILTON, D0 |
| FELIX J BAKER | Director | HAMILTON, D0 |
| SANJ K PATEL | Director | HAMILTON, D0 |
| SANJ K PATEL | Executive Officer | HAMILTON, D0 |
| THOMAS R MALLEY | Director | HAMILTON, D0 |
| Stephen Biggar | Director | New York, NY |
| SRINI J AKKARAJU | Director | LEXINGTON, MA |
| ROBYN R SAMUELS | Director | LEXINGTON, MA |
| Mark K Goldberg | Director | Waltham, MA |
| James K Tullis | Director | Waltham, MA |
| Srini K Akkaraju | Director | Waltham, MA |
| Robyn K Samuels | Director | Waltham, MA |
| Thomas K Malley | Director | Waltham, MA |
| Stephen K Biggar | Director | Waltham, MA |
| Felix K Baker | Director | Waltham, MA |
| Robyn Samuels | Director | Waltham, MA |
| Lyle Hohnke | Director | Waltham, MA |
Other filings by this issuer (3)
More